CoraLite®594-conjugated ITM2C Monoclonal antibody

ITM2C Monoclonal Antibody for IF

Host / Isotype

Mouse / IgG2a

Reactivity

human, canine

Applications

IF

Conjugate

CoraLite®594 Fluorescent Dye

CloneNo.

2E8G11

Cat no : CL594-60095

Synonyms

BRI3, BRICD2C, Cerebral protein 14, E25, E25C, integral membrane protein 2C, ITM2C, ITM3, PSEC0047, Transmembrane protein BRI3



Tested Applications

Positive IF detected inMDCK cells, HepG2 cells
For other applications, we recommend the unconjugated version of this antibody, 60095-1-Ig

Recommended dilution

ApplicationDilution
Immunofluorescence (IF)IF : 1:50-1:500
Sample-dependent, check data in validation data gallery

Product Information

CL594-60095 targets ITM2C in IF applications and shows reactivity with human, canine samples.

Tested Reactivity human, canine
Host / Isotype Mouse / IgG2a
Class Monoclonal
Type Antibody
Immunogen ITM2C fusion protein Ag4409 相同性解析による交差性が予測される生物種
Full Name integral membrane protein 2C
Calculated molecular weight230aa,26 kDa; 267aa,30 kDa
Observed molecular weight 35 kDa
GenBank accession numberBC025742
Gene symbol ITM2C
Gene ID (NCBI) 81618
RRIDAB_2883421
Conjugate CoraLite®594 Fluorescent Dye
Excitation/Emission maxima wavelengths588 nm / 604 nm
Form Liquid
Purification Method Protein A purification
Storage Buffer PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
Storage ConditionsStore at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

The Integral membrane protein 2C (ITM2C) is a type II integral transmembrane protein belonging to a family composed of at least two other members, ITM2A and ITM2B. ITM2C, often called transmembrane protein BRI3, is highly expressed in brain tissue. Yeast two-hybrid screen system revealed that BRI3 could interact with beta-secretase beta-amyloid protein converting enzyme (BACE)1 and the microtubule-destabilizing protein SCG10 (STMN2). It may play a role in TNF-induced cell death and neuronal differentiation. BRI3 was found to inhibit the various processing of amyloid precursor protein (APP) by blocking the access of alpha- and beta-secretases to APP, competitive inhibition of APP processing by BRI3 may provide a new approach to Alzheimer disease (AD) therapy and prevention.

Protocols

Product Specific Protocols
IF protocol for CL594 ITM2C antibody CL594-60095Download protocol
Standard Protocols
Click here to view our Standard Protocols